Cover ImageSALE
Market Research Report

Global Animal Healthcare Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 603609
Published Content info 118 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Animal Healthcare Market 2018-2022
Published: February 6, 2018 Content info: 118 Pages
Description

About Animal Healthcare

Animal healthcare involves guarding, preserving, and preventing disease in and providing necessary veterinary services to animals to enhance their quality of life, increase their lifespan, and increase the yield of animal foods.

Technavio's analysts forecast the global animal healthcare market is expected to grow to USD 32.04 billion during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global animal healthcare market for 2018-2022. To calculate the market size, the report considers the revenue generated from the retail sales of products which includes pharmaceutical, feed additive, and biological in the Americas, EMEA, and APAC.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Animal Healthcare Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer 91
  • Boehringer Ingelheim 95
  • Eli Lilly 100
  • Merck 105
  • Zoetis

Market driver

  • Increase in animal ownership
  • For a full, detailed list, view our report

Market challenge

  • Contamination of animal source foods
  • For a full, detailed list, view our report

Market trend

  • Growing animal healthcare awareness
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR21097

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Pharmaceutical
  • Feed additive
  • Biologicals
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Growing animal healthcare awareness
  • Increasing M&A activity
  • Increase in consumer preference towards protein-rich food

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Zoetis
  • Other prominent vendors
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 08: Global - Year over year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017
  • Exhibit 17: Product - Market share 2017-2022 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Pharmaceutical - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 20: Pharmaceutical - Year over year growth 2018-2022 (%)
  • Exhibit 21: Feed additive - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 22: Feed additive - Year over year growth 2018-2022 (%)
  • Exhibit 23: Biologicals- Market size and forecast 2017-2022 ($ bn)
  • Exhibit 24: Biologicals- Year over year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global - Market share by geography 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 30: Americas - Year over year growth 2018-2022 (%)
  • Exhibit 31: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 32: EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 33: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 34: APAC - Year over year growth 2018-2022 (%)
  • Exhibit 35: Key leading countries
  • Exhibit 36: Market opportunity
  • Exhibit 37: Diseases caused by animals and their mode of transmission to humans
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Vendor overview
  • Exhibit 44: Bayer - Business segments
  • Exhibit 45: Bayer - Organizational developments
  • Exhibit 46: Bayer - Geographic focus
  • Exhibit 47: Bayer - Segment focus
  • Exhibit 48: Bayer - Key offerings
  • Exhibit 49: Vendor overview
  • Exhibit 50: Boehringer Ingelheim- Business segments
  • Exhibit 51: Boehringer Ingelheim - Organizational developments
  • Exhibit 52: Boehringer Ingelheim- Geographic focus
  • Exhibit 53: Boehringer Ingelheim- Segment focus
  • Exhibit 54: Boehringer Ingelheim- Key offerings
  • Exhibit 55: Vendor overview
  • Exhibit 56: Eli Lilly- Business segments
  • Exhibit 57: Eli Lilly- Organizational developments
  • Exhibit 58: Eli Lilly- Geographic focus
  • Exhibit 59: Eli Lilly- Segment focus
  • Exhibit 60: Eli Lilly- Key offerings
  • Exhibit 61: Vendor overview
  • Exhibit 62: Merck- Business segments
  • Exhibit 63: Merck- Organizational developments
  • Exhibit 64: Merck- Geographic focus
  • Exhibit 65: Merck- Segment focus
  • Exhibit 66: Merck- Key offerings
  • Exhibit 67: Vendor overview
  • Exhibit 68: Zoetis- Business segments
  • Exhibit 69: Zoetis- Organizational developments
  • Exhibit 70: Zoetis- Geographic focus
  • Exhibit 71: Zoetis- Segment focus
  • Exhibit 72: Zoetis- Key offerings
Back to Top